SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Epigral

BSE: 543332 02 Jun 2025
Commodities
₹ 1785
Epigral Limited specializes in Specialty Chemicals within the Commodities sector.

Epigral - Share Price & Details

Market Cap
₹7,597
High /Low
2,408 / 1,107
Stock P/E
21.2
Book Value
₹441.0
Dividend Yield
0.29
ROCE
25.2
ROE
₹22.6
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹11.3
Debt
593
CMP / FCF
49.3
Debt to equity
₹0.31
NP Ann
358
High price all time
2,408
Piotroski score
₹8.0
Graham Number
908.0
No. Eq. Shares
4.31
Net CF
₹15.5
Net profit
358
Price to book value
4.0
Interest Coverage
₹11.2
Low price all time
386.0
Industry PE
31.3
Reserves
₹1,861
Free Cash Flow
₹254

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Southern Gas Ltd.,NANANANA0.050.03
Indo Gulf Industries Ltd.,NANANANA0
Epigral Limited6310.3866.26276.320.087,59721.2
DHANUKA AGRITECH LTD.4531.79755.024420.2316.74752025.3
ORIENT CEMENT LTD8328.41420.78251.882.05719778.9

Peer Comparison Chart


About Epigral

Epigral Limited, with Security Code 543332, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Latest News

Coffee Day Enterprises Ltd leads gainers in 'A' group

(16 May 2025)
Vijaya Diagnostic Centre Ltd, Jyoti CNC Automation Ltd, India Cements Ltd and Epigral Ltd are among the other gainers in the BSE's 'A' group today,...
Read more →

Indian manufacturers contest exemption of Epigral’s special grade PVC from anti-dumping duty

(11 May 2025)
Indian polyvinyl chloride (PVC) manufacturers have challenged the Gujarat High Court (HC) order allo...
Read more →

Epigral Limited Reports Q4 FY25 Profit Growth of 13% to ₹87 Crore

(10 May 2025)
Epigral Limited, a leading integrated chemical manufacturer in India, reported a 13% year-on-year increase in profit after tax (PAT) to ₹87...
Read more →

Epigral Reports Q4FY25 PAT Growth of 13% to Rs 870 Million

(10 May 2025)
Epigral Limited, a leading integrated chemical manufacturer in India, announced its financial results for the quarter ended March 31, 2025.
Read more →

Epigral Q4 net profit rises 13% to Rs 87 crore

(05 May 2025)
Epigral reported a 13% increase in net profit, reaching ₹87 crore for the March quarter, with revenue up 20% to ₹631 crore.
Read more →

Epigral Q4 FY25: Net profit up 13% at Rs 87 crore; Rs 3.5 per share final dividend declared

(05 May 2025)
Epigral announces plans to expand its CPVC and Epichlorohydrin capacity by FY2027, aiming to boost its growth trajectory.
Read more →